Leidos Bags $53M Task Order For Warfighter Performance Research
Leidos Holdings Inc (NYSE:LDOS) has secured a new task order from Naval Medical Readiness Logistics Command, Detachment Fort Detrick, formerly Naval…
Leidos’ DES Contract Win, Largest in Company History, is Upheld by the GAO
Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, announced today that the Defense Enclave Services (DES) contract awarded by the Defense Information Systems Agency (DISA) was upheld by the
Barclays Downgrades Leidos Holdings to Equal-Weight
Barclays analyst Colin Canfield downgrades Leidos Holdings (NYSE:LDOS) from Overweight to Equal-Weight.
Leidos Company QTC Medical Services Announces $1.7B In Veteran And Service Member Medical Disability Exam Contracts
RESTON, Va., May 31, 2022 /PRNewswire/ -- QTC Medical Services, Inc. (QTC), a Leidos (NYSE:LDOS) company, was recently awarded two prime contracts to provide medical disability examination services to
Wells Fargo Maintains Equal-Weight on Leidos Holdings, Lowers Price Target to $109
Wells Fargo analyst Matthew Akers maintains Leidos Holdings (NYSE:LDOS) with a Equal-Weight and lowers the price target from $113 to $109.
Leidos Beats Q1 Aided By Government Technology Market; Reiterates FY22 Guidance
Leidos Holdings, Inc (NYSE:LDOS) reported first-quarter FY22 revenue growth of 5% year-on-year to $3.49 billion, beating the consensus of $3.38 billion.…
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
What 5 Analyst Ratings Have To Say About Leidos Holdings
Within the last quarter, Leidos Holdings (NYSE:LDOS) has observed the following analyst ratings:
Goldman Sachs Maintains Buy on Leidos Holdings, Raises Price Target to $132
Goldman Sachs maintains Leidos Holdings (NYSE:LDOS) with a Buy and raises the price target from $118 to $132.